Obsessive-compulsive disorder: Current and emerging treatment options

Authors

  • Ella Kim The Spence School
  • Scott Godsen The Spence School

DOI:

https://doi.org/10.47611/jsrhs.v12i4.5492

Keywords:

obsessive-compulsive disorder, OCD, cognitive behavioral therapy, exposure response therapy, ERP, SSRI, clomipramine, ketamine, Bergen 4-day treatment, Transcranial magnetic stimulation, TMS, CBT

Abstract

Obsessive-compulsive disorder (OCD) is a chronic psychiatric disorder that can result in significant functional impairment. The cost to society is both direct due to increased healthcare costs and indirect due to reduced productivity. For patients, it can lead to profound disability and greatly affect their quality of life. Due to the complex nature of the disorder, both diagnosis and treatment are often delayed, leading to poorer outcomes. Currently, first-line treatments for OCD consist of psychotherapy, medications or both. Unfortunately, both interventions, in conjunction or as monotherapy, take several months to take effect. In addition, only a fraction of patients with OCD sees a sufficient response to treatment. As a result, it is important for researchers and health care providers to continue investigating new treatments that may be more efficacious or reduce the time it takes for patients to respond. Three such treatments - the Bergen 4-day treatment, ketamine, and transcranial magnetic stimulation - will be discussed as well as reviewing the currently recommended treatments.

Downloads

Download data is not yet available.

Author Biography

Scott Godsen, The Spence School

Science teacher

References or Bibliography

Adams, T. G., Bloch, M. H., & Pittenger, C. (2017). Intranasal Ketamine and Cognitive-Behavioral Therapy for

Treatment-Refractory Obsessive-Compulsive Disorder. Journal of clinical psychopharmacology, 37(2),

–271. https://doi.org/10.1097/JCP.0000000000000659

American Psychiatric Association (APA). (2007) Practice Guidelines for the Treatment of Patients with Obsessive-

Compulsive Disorder. American Psychiatric Association (APA).

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders, fifth edition.

American Psychiatric Association.

Bandeira, I. D., Lins-Silva, D. H., Cavenaghi, V. B., Dorea-Bandeira, I., Faria-Guimarães, D., Barouh, J. L., Jesus-

Nunes, A. P., Beanes, G., Souza, L. S., Leal, G. C., Sanacora, G., Miguel, E. C., Sampaio, A. S., &

Quarantini, L. C. (2022). Ketamine in the Treatment of Obsessive-Compulsive Disorder: A Systematic

Review. Harvard review of psychiatry, 30(2), 135–145. https://doi.org/10.1097/HRP.0000000000000330

Bloch, M. H., Wasylink, S., Landeros-Weisenberger, A., Panza, K. E., Billingslea, E., Leckman, J. F., Krystal, J. H.,

Bhagwagar, Z., Sanacora, G., & Pittenger, C. (2012). Effects of ketamine in treatment-refractory obsessive-

compulsive disorder. Biological psychiatry, 72(11), 964–970.

https://doi.org/10.1016/j.biopsych.2012.05.028

Bottemanne, H. & Arnould, A. (2021) Ketamine Augmentation of Exposure Response Prevention Therapy for

Obsessive-compulsive Disorder. Innovations in clinical neuroscience, 18(10-12), 9-11.

Carmi, L., Tendler, A., Bystritsky, A., Hollander, E., Blumberger, D. M., Daskalakis, J., Ward, H., Lapidus, K.,

Goodman, W., Casuto, L., Feifel, D., Barnea-Ygael, N., Roth, Y., Zangen, A., & Zohar, J. (2019). Efficacy

and Safety of Deep Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Prospective

Multicenter Randomized Double-Blind Placebo-Controlled Trial. The American journal of

psychiatry, 176(11), 931–938. https://doi.org/10.1176/appi.ajp.2019.18101180

Davíðsdóttir, S. D., Sigurjónsdóttir, Ó., Ludvigsdóttir, S. J., Hansen, B., Laukvik, I. L., Hagen, K., Björgvinsson, T.,

& Kvale, G. (2019). Implementation of the Bergen 4-Day Treatment for Obsessive Compulsive Disorder in

Iceland. Clinical neuropsychiatry, 16(1), 33–38.

Del Casale, A., Sorice, S., Padovano, A., Simmaco, M., Ferracuti, S., Lamis, D.A., Rapinesi, C., Sani, G., Girardi, P.,

Kotzalidis, G.D., & Pompili, M. (2019). Psychopharmacological Treatment of Obsessive-Compulsive

Disorder (OCD). Current neuropharmacology 17(8), 710-736.

https://doi.org/10.2174/1570159X16666180813155017

Dell'Osso, B., Benatti, B., Grancini, B., Vismara, M., De Carlo, V., Cirnigliaro, G., Albert, U., & Viganò, C. (2019).

Investigating duration of illness and duration of untreated illness in obsessive compulsive disorder reveals

patients remain at length pharmacologically untreated. International journal of psychiatry in clinical

practice, 23(4), 311–313. https://doi.org/10.1080/13651501.2019.1621348

Dinur-Klein, L., Dannon, P., Hadar, A., Rosenberg, O., Roth, Y., Kotler, M., & Zangen, A. (2014). Smoking

cessation induced by deep repetitive transcranial magnetic stimulation of the prefrontal and insular cortices:

a prospective, randomized controlled trial. Biological psychiatry, 76(9), 742–749.

https://doi.org/10.1016/j.biopsych.2014.05.020

Fineberg, N. A., Pampaloni, I., Pallanti, S., Ipser, J., & Stein, D. J. (2007). Sustained response versus relapse: the

pharmacotherapeutic goal for obsessive-compulsive disorder. International clinical

psychopharmacology, 22(6), 313–322. https://doi.org/10.1097/YIC.0b013e32825ea312

Fineberg, N. A., Reghunandanan, S., Simpson, H. B., Phillips, K. A., Richter, M. A., Matthews, K., Stein, D. J.,

Sareen, J., Brown, A., Sookman, D., & Accreditation Task Force of The Canadian Institute for Obsessive

Compulsive Disorders (2015). Obsessive-compulsive disorder (OCD): Practical strategies for

pharmacological and somatic treatment in adults. Psychiatry research, 227(1), 114–125.

https://doi.org/10.1016/j.psychres.2014.12.003

Fineberg, N.A., Dell’Osso B., Albert U., Maina, G., Geller, D., Carmi, L., Sireau, N., Walitza, S., Grassi, G.,

Pallanti, S., Hollander, E., Brakoulias, V., Menchon, J.M., Marazziti, D., Ioannidis, K., Apergis-Schoute,

A., Stein, D.J., Cath, D.C., Veltman, D.J.,…Zohar, J. (2019). Early intervention for obsessive compulsive

disorder: An expert consensus statement. European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology, 29(4): 549-565. https://doi.org/10.1016/j.euroneuro.2019.02.002

Hansen, B., Hagen, K., Öst, L. G., Solem, S., & Kvale, G. (2018). The Bergen 4-Day OCD Treatment Delivered in a

Group Setting: 12-Month Follow-Up. Frontiers in psychology, 9, 639.

https://doi.org/10.3389/fpsyg.2018.00639

Hansen, B., Kvale, G., Hagen, K., Havnen, A., & Öst, L. G. (2019). The Bergen 4-day treatment for OCD: four

years follow-up of concentrated ERP in a clinical mental health setting. Cognitive behaviour

therapy, 48(2), 89–105. https://doi.org/10.1080/16506073.2018.1478447

Hirschtritt, M.E., Bloch, M.H., & Mathews, C.A. (2017). Obsessive-compulsive disorder: advances in diagnosis and

treatment. JAMA, 317(13): 1358-1367. https://doi.org/10.1001/jama.2017.2200

Isserles, M., Shalev, A. Y., Roth, Y., Peri, T., Kutz, I., Zlotnick, E., & Zangen, A. (2013). Effectiveness of deep

transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress

disorder--a pilot study. Brain stimulation, 6(3), 377–383. https://doi.org/10.1016/j.brs.2012.07.008

Kammen, A., Cavaleri, J., Lam, J., Frank, A. C., Mason, X., Choi, W., Penn, M., Brasfield, K., Van Noppen, B.,

Murray, S. B., & Lee, D. J. (2022). Neuromodulation of OCD: A review of invasive and non-invasive

methods. Frontiers in neurology, 13, 909264. https://doi.org/10.3389/fneur.2022.909264

Katerberg, H., Delucchi, K. L., Stewart, S. E., Lochner, C., Denys, D. A., Stack, D. E., Andresen, J. M., Grant, J. E.,

Kim, S. W., Williams, K. A., den Boer, J. A., van Balkom, A. J., Smit, J. H., van Oppen, P., Polman, A.,

Jenike, M. A., Stein, D. J., Mathews, C. A., & Cath, D. C. (2010). Symptom dimensions in OCD: item-level

factor analysis and heritability estimates. Behavior genetics, 40(4), 505–517.

https://doi.org/10.1007/s10519-010-9339-z

Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005). Lifetime prevalence

and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey

Replication. Archives of general psychiatry, 62(6), 593–602. https://doi.org/10.1001/archpsyc.62.6.593

Koran, L.M., Hanna, G.I., Hollander, E., Nestadt, G., Simpson, H.B., & American Psychiatric Association (2007).

Practice guideline for the treatment of patients with obsessive-compulsive disorder. The American journal

of psychiatry, 164(7 Suppl), 5-53.

Launes, G., Hagen, K., Sunde, T., Öst, L. G., Klovning, I., Laukvik, I. L., Himle, J. A., Solem, S., Hystad, S. W.,

Hansen, B., & Kvale, G. (2019). A Randomized Controlled Trial of Concentrated ERP, Self-Help and

Waiting List for Obsessive-Compulsive Disorder: The Bergen 4-Day Treatment. Frontiers in

psychology, 10, 2500. https://doi.org/10.3389/fpsyg.2019.02500

Lenz, M., Galanis, C., Müller-Dahlhaus, F., Opitz, A., Wierenga, C.J., Szabó, G., Ziemann, U., Deller, T., Funke, K.

& Vlachos, A. (2016). Repetitive magnetic stimulation induces plasticity of inhibitory synapses. Nature

Communications, 7, 10020. https://doi.org/10.1038/ncomms10020

Liang, K., Li, H., Bu, X., Li, X., Cao, L., Liu, J., Gao, Y., Li, B., Qiu, C., Bao, W., Zhang, S., Hu, X., Xing, H.,

Gong, Q., & Huang, X. (2021). Efficacy and tolerability of repetitive transcranial magnetic stimulation for

the treatment of obsessive-compulsive disorder in adults: a systematic review and network meta-

analysis. Translational psychiatry, 11(1), 332. https://doi.org/10.1038/s41398-021-01453-0

Mataix-Cols, D., Wooderson, S., Lawrence, N., Brammer, M. J., Speckens, A., & Phillips, M. L. (2004). Distinct

neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive

disorder. Archives of general psychiatry, 61(6), 564–576. https://doi.org/10.1001/archpsyc.61.6.564

National Institute for Health and Care Excellence (NICE). (2005) Obsessive-compulsive disorder and body

dysmorphic disorder: treatment. National Institute for Health and Care Excellence (NICE).

Perera, M. P. N., Mallawaarachchi, S., Miljevic, A., Bailey, N. W., Herring, S. E., & Fitzgerald, P. B. (2021).

Repetitive Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Meta-analysis of

Randomized, Sham-Controlled Trials. Biological psychiatry. Cognitive neuroscience and

neuroimaging, 6(10), 947–960. https://doi.org/10.1016/j.bpsc.2021.03.010

Rapinesi, C., Kotzalidis, G. D., Ferracuti, S., Sani, G., Girardi, P., & Del Casale, A. (2019). Brain Stimulation in

Obsessive-Compulsive Disorder (OCD): A Systematic Review. Current neuropharmacology, 17(8), 787–

https://doi.org/10.2174/1570159X17666190409142555

Rasmussen, S.A., & Eisen, J.L. (1994). The epidemiology and differential diagnosis of obsessive compulsive

disorder. The Journal of clinical psychiatry, 55 Suppl, 5-14.

Reid, J.E., Laws, K.R., Drummond, L., Vismara, M., Grancini, B., Mpavaenda, D., & Fineberg, N.A. (2021)

Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-

compulsive disorder: A systematic review and meta-analysis of randomized controlled trials. Comprehensive Psychiatry, 106, 152223. https://doi.org/10.1016/j.comppsych.2021.152223

Rodriguez, C.I., Kegeles, L.S., Flood, P., & Simpson, H.B. (2011). Rapid Resolution of Obsessions After an Infusion

of Intravenous Ketamine in a Patient with Treatment-Resistant Obsessive-Compulsive Disorder: A Case

Report. (2011) Journal of clinical psychiatry, 72(4), 567-569. https://doi.org/10.4088/JCP.10I06653

Rodriguez, C. I., Kegeles, L. S., Levinson, A., Feng, T., Marcus, S. M., Vermes, D., Flood, P., & Simpson, H. B.

(2013). Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-

concept. Neuropsychopharmacology: official publication of the American College of

Neuropsychopharmacology, 38(12), 2475–2483. https://doi.org/10.1038/npp.2013.150

Rodriguez, C. I., Kegeles, L. S., Levinson, A., Ogden, R. T., Mao, X., Milak, M. S., Vermes, D., Xie, S., Hunter, L.,

Flood, P., Moore, H., Shungu, D. C., & Simpson, H. B. (2015). In vivo effects of ketamine on glutamate-

glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept. Psychiatry

research, 233(2), 141–147. https://doi.org/10.1016/j.pscychresns.2015.06.001

Ruscio, A.M., Stein, D.J., Chiu, W.T., & Kessler, R.C. (2010). The epidemiology of obsessive-compulsive disorder

in the National Comorbidity Survey Replication. Molecular psychiatry, 15(1), 53-63.

https://doi.org/10.1038/mp.2008.94

Sharma, L. P., Thamby, A., Balachander, S., Janardhanan, C. N., Jaisoorya, T. S., Arumugham, S. S., & Reddy, Y. C.

J. (2020). Clinical utility of repeated intravenous ketamine treatment for resistant obsessive-compulsive

disorder. Asian journal of psychiatry, 52, 102183. https://doi.org/10.1016/j.ajp.2020.102183

Simpson, H.B., Maher, M.J., Wang, Y., Bao, Y., Foa, E.B., & Franklin, M. (2011). Patient adherence predicts

outcome from cognitive-behavioral therapy in obsessive-compulsive disorder.

Journal of Consulting and Clinical Psychology, 79(2), 247-252. https://doi.org/10.1037/a0022659

Stein, D.J., Costa, D.L.C., Lochner, C., Miguel, E.C., Reddy, Y.C.J., Shavitt, R.G., van den Heuvel, O.A., &

Simpson, H.B. (2019). Obsessive-compulsive disorder. Nature reviews. Disease primers, 5(1): 52.

https://doi.org/10.1038/s41572-019-0102-3.

Szechtman, H., Harvey, B.H., Woody, E.Z., & Hoffman, K.L. (2020) The Psychopharmacology of Obsessive-

Compulsive Disorder: A Preclinical Roadmap. Pharmacological reviews, 72(1), 80-151.

https://doi.org/10.1124.pr.119.017772

Van den Eynde, F., Claudino, A. M., Mogg, A., Horrell, L., Stahl, D., Ribeiro, W., Uher, R., Campbell, I., &

Schmidt, U. (2010). Repetitive transcranial magnetic stimulation reduces cue-induced food craving in

bulimic disorders. Biological psychiatry, 67(8), 793–795. https://doi.org/10.1016/j.biopsych.2009.11.023

World Health Organization (WHO). (2008). The Global Burden of Disease: 2004 Update. World Health

Organization.

Published

11-30-2023

How to Cite

Kim, E., & Godsen, S. (2023). Obsessive-compulsive disorder: Current and emerging treatment options. Journal of Student Research, 12(4). https://doi.org/10.47611/jsrhs.v12i4.5492

Issue

Section

HS Review Articles